查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1371965

全球生物感測器市場，到 2030 年的市場預測：按類型、產品、技術、用途和地區進行的全球分析

Biosensor Market Forecasts to 2030 - Global Analysis By Type (Embedded Device, Sensor Patch and Other Types), Product (Non-wearable Biosensors and Wearable Biosensors), Technology, Application and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2023年全球生物感測器市場規模為294.8億美元，預計2030年將達到574.4億美元，預測期內年複合成長率為10.0%。

生物感測器是一種用於感測或檢測生物物質（主要是生物分子和細菌）的存在或濃度的醫療設備。它是一種可以將生物反應轉化為電訊號的分析工具。食品和飲料、環境監測、家庭護理診斷和其他奈米機械生物感測器只是生物感測器應用的幾個領域。

根據國際糖尿病聯盟的數據，糖尿病正以每年約 8.0% 的速度成長。到 2035 年，預計將有超過 5.9 億人患有糖尿病，這意味著在整個預測期內市場將快速擴張。

生物感測器在醫療領域的廣泛應用

生物感測器具有特殊的標準，即疾病預後和患者生存取決於早期和準確的疾病診斷。近年來，對簡單、拋棄式、易於使用、經濟高效且響應時間快的設備的需求量很大。用於自我檢查、即時檢測和血糖監測的生物感測器在實驗室中使用和商業性開發。這些生物感測器使用電化學和光學傳輸模式來檢測葡萄糖、尿素、肌酸酐、乳酸和其他物質。此外，生物感測器的應用可以在醫療保健領域的許多領域找到，例如癌症、糖尿病和循環系統疾病。隨著這些疾病在全球範圍內的患病增加，擴大使用生物感測器來早期檢測這些疾病。生物感測器非常適合醫院、家庭患者和非醫院環境中的看護者的新用途，從而推動了生物感測器的使用。

高成本

生物感測器技術的開發、生產和部署需要複雜的製程、專用材料和先進的製造技術，這增加了整體成本。這些成本構成了普及的障礙，特別是在資源有限的醫療機構和成本效益敏感的行業。負擔得起對於生物感測器更廣泛地傳播和融入各種用途普及，為了克服這一市場抑制因素並推動市場成長，透過技術進步和簡化製造流程來降低成本增加，努力減少這一點至關重要。

製藥業對生物感測器的需求不斷成長

生物感測器在製藥業中發揮重要作用，有助於藥物開發、監測和品管。在藥物開發中，生物感測器用於研究潛在藥物化合物與生物分子的相互作用，幫助鑒定和最佳化候選藥物。在藥物傳遞系統中，生物感測器有助於最佳化給藥並確保精確的藥物釋放，從而提高治療效果。製藥業的品管在很大程度上依賴生物感測器進行批量測試和驗證。生物感測器可準確檢測和定量特定生物分子，確保藥品的純度、效力和穩定性。因此，生物感測器為製藥業提供了支持藥物研發、開發和品質保證的寶貴工具，最終有助於醫療保健的進步和改善患者的治療結果。

資料隱私問題

資料隱私問題是生物感測器市場的主要抑制因素。生物感測器收集和傳輸與健康相關的敏感資料，引發了對資料隱私和安​​全的擔憂。由於擔心個人健康資訊可能被濫用或詐欺訪問，使用者越來越不願意採用生物感測器，尤其是穿戴式裝置。更嚴格的資料隱私法規和對這些問題的認知的提高將影響使用者的信任和接受度。因此，透過有效的資料加密、開放的資料處理實踐以及遵守嚴格的隱私法來解決這些問題，將減輕人們的擔憂，並鼓勵生物感測器在醫療保健和其他行業的廣泛採用，對此的推廣極為重要。

COVID-19 的影響

COVID-19的爆發對全球生物感測器市場產生了重大影響。為了因應新型冠狀病毒肺炎（COVID-19）疫情，許多學術機構和重要企業顯著加強了生物感測器的研發力道。例如，根據美國科學促進會（AAAS）介紹，瑞士聯邦材料科學技術研究所和蘇黎世聯邦理工學院的王靖及其團隊開發了一種可以特異性識別SARS-CoV-2的POC生物感測器。曾做過。在臨床診斷中使用這種感測器來即時監測空氣中的病毒量，可以取代但不能取代傳統的實驗室檢測。同樣，為了開發用於 COVID-19 測試的生物感測器，電子機械系統和感測器製造商 Rogue Valley Microdevices 正在與 Chaldea Bio & Hemics 等階段公司合作。因此，這些要素預計將在整個預測期內推動市場擴張。

嵌入式設備領域預計將在預測期內成為最大的領域

由於醫療保健、環境監測、食品和飲料以及家用電子電器等多個行業對嵌入式生物感測器的需求大幅成長，嵌入式設備領域預計將佔據最大佔有率。嵌入式設備是生物感測器的重要子集，它將生物感測器技術整合到各種系統、產品或平台中，增強其功能並實現即時監控和分析。此外，這些生物感測器還可應用於糖尿病管理的連續血糖監測、穿戴式健康追蹤器、環境污染監測和食品產業的智慧包裝。

預計醫療保健領域在預測期內年複合成長率最高

預計醫療保健領域在預測期內將出現良好成長。生物感測器市場的醫療保健領域正在對患者照護、疾病管理和診斷產生變革性影響。生物感測器具有廣泛的應用，包括糖尿病的血糖監測、心臟生物標記檢測、懷孕檢測、感染疾病診斷和藥物水平監測。一項重要的進步是穿戴式生物感測器的開發，它有助於對生命徵象、血糖水平和其他健康參數進行連續、非侵入性監測。除此之外，這些穿戴式裝置還為患者和醫療保健專業人員提供有價值的資料，從而實現對慢性病的主動管理和及時干涉。醫療保健領域是一個重要且不斷成長的細分市場，有可能徹底改變醫療保健服務並改善患者的治療結果。

比最大的地區

由於人口眾多且各種文明病的發生率不斷上升，亞太地區在估計期間佔據了最大的市場佔有率。該地區對家庭醫療保健、定點醫療服務和其他成人醫療保健業務的需求不斷增加，政府也尋求透過開發門診病人護理模式來減少住院時間。此外，還有一些配合措施。各國政府、世界衛生組織和克林頓健康計劃公司（CHAI）等組織發起的一系列衛生計劃也推動了該地區的統計數據。此外，在提供區域資料的預測分析時，還將考慮全球品牌的存在和可用性、由於本地和國家品牌的競爭或多或少而面臨的挑戰、國內關稅的影響、貿易路線等。完成。

複合年複合成長率最高的地區：

預計北美在預測期內將實現盈利成長。該地區擴大使用生物感測器來追蹤食品品質指標，預計將支持市場成長。電子健康記錄（EMR）市場滲透率的上升和小型化診斷設備的市場開拓預計將在預測期內推動市場擴張。此外，美國《清潔空氣法》、《水污染控制法》和《國家環境政策法》的推出預計將擴大北美市場擴張的機會。此外，北美對 POC 技術的需求不斷成長，以及對快速、簡單、準確、攜帶式和低成本分析儀器的關注，將推動該地區生物感測器市場的成長。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究來源
    • 主要研究來源
    • 二次研究來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球生物感測器市場：按類型

  • 嵌入式裝置
  • 感應器貼片
  • 其他類型

第6章 全球生物感測器市場：按產品

  • 非穿戴式生物感測器
  • 穿戴式生物感測器

第7章 全球生物感測器市場：依技術分類

  • 電化學生物感測器
  • 壓電生物感測器
  • 奈米機械生物感測器
  • 光學生物感測器
  • 熱生物感測器
  • 其他技術

第8章 全球生物感測器市場：依用途

  • 醫療測試
    • 血糖測試
    • 血氣分析
    • 膽固醇測試
    • 懷孕測試
    • 傳染病檢查
  • 藥物研發
  • 食物中毒
  • 農業檢測
  • 工業製程
  • 污水處理
  • 衛生保健
  • 法醫學/生物防禦
  • 食品/飲料
  • 即時檢測
  • 研究
  • 其他用途

第9章 全球生物感測器市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Bio-rad Laboratories
  • Nova biomedical
  • Acon laboratories
  • Eastprint incorporated
  • SD biosensor
  • Medtronic
  • Universal Biosensors
  • Conductive technologies
  • F. Hoffmann-La Roche Ltd
  • Innovative Sensor Technology AG
  • Pinnacle Technology
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Biosensors International Group, Ltd
  • Dexcom, Inc.
  • QTL Biosystems
  • Danaher Corporation
  • DuPont Biosensor Materials
  • Johnson & Johnson
Product Code: SMRC24022

According to Stratistics MRC, the Global Biosensor Market is accounted for $29.48 billion in 2023 and is expected to reach $57.44 billion by 2030 growing at a CAGR of 10.0% during the forecast period. Biosensors are medical devices that are used primarily to sense or detect the presence or concentration of biological material, such as a biomolecule or a bacterium. They are analytical tools that can transform a biological reaction into an electrical signal. Food and beverages, environmental monitoring, home care diagnostics, and other nanomechanical biosensors are just a few areas where biosensors are used.

According to the International Diabetic Federation, diabetes is rising at an annual rate of about 8.0 percent. More than 590 million people are expected to develop diabetes by 2035, implying that the market would increase rapidly throughout the projected period.

Market Dynamics:

Driver:

Extensive biosensor applications in medical fields

Biosensors have specialised criteria, which include that the prognosis of diseases and the survival of patients depend on an early and accurate disease diagnosis. Simple, disposable, user-friendly, and cost-effective devices with quick response times have become much more in demand in recent years. In laboratories, biosensors for self-testing, point-of-care testing, and glucose monitoring are being used and commercially developed. These biosensors measure glucose, urea, creatinine, lactate, and other substances using electrochemical and optical modes of transduction. Moreover, applications for biosensors can be found in many areas of the healthcare sector, including cancer, diabetes, and cardiovascular conditions. The use of biosensors for these diseases' early detection has increased as their prevalence around the globe has increased. Biosensors are ideal for new applications in hospitals, by patients at home, and by carers in non-hospital settings, thus boosting the use of biosensors.

Restraint:

High cost

The development, production, and implementation of biosensor technology involve complex processes, specialized materials, and advanced manufacturing techniques, driving up the overall cost. These expenses pose a barrier to widespread adoption, especially in resource-limited healthcare settings and industries sensitive to cost-efficiency. Affordability is crucial for broader accessibility and integration of biosensors into various applications, and efforts to mitigate costs through technological advancements and streamlined manufacturing processes are essential to overcoming this restraint and promoting market growth.

Opportunity:

Rising demand for biosensors in the pharmaceutical industry

Biosensors have a vital role in the pharmaceutical industry, contributing to drug development, monitoring, and quality control. During drug development, biosensors are employed to study the interactions between potential drug compounds and biological molecules, aiding in the identification and optimisation of drug candidates. In drug delivery systems, biosensors assist in optimising dosages and ensuring precise drug release, enhancing therapeutic outcomes. Quality control within the pharmaceutical industry heavily relies on biosensors for batch testing and validation. Biosensors can accurately detect and quantify specific biomolecules, ensuring the purity, potency, and stability of drugs. Thus, biosensors offer invaluable tools in the pharmaceutical sector, supporting drug discovery, development, and quality assurance, ultimately contributing to the advancement of healthcare and the improvement of patient outcomes.

Threat:

Data privacy concerns

Data privacy concerns present a significant restraint in the biosensor market. As biosensors collect and transmit sensitive health-related data, there's growing apprehension regarding data privacy and security. Users worry about potential misuse or unauthorised access to their personal health information, leading to reluctance to adopt biosensors, particularly wearables. Stricter data privacy regulations and increasing awareness of these concerns impact user trust and acceptance. Therefore, it is crucial to reduce concerns and promote a wider adoption of biosensors in healthcare and other industries by addressing these issues through effective data encryption, openness in data handling practices, and adherence to strict privacy legislation.

COVID-19 Impact

The COVID-19 epidemic had a huge impact on the world biosensor market. Numerous academic institutions and significant businesses have significantly raised their biosensor research and development in response to the COVID-19 epidemic. For instance, Jing Wang and his team at the Swiss Federal Laboratories for Materials Science and Technology and ETH Zurich have created a point-of-care biosensor that can specifically identify SARS-CoV-2, according to the American Association for the Advancement of Science (AAAS). The use of this sensor for clinical diagnosis and real-time monitoring of virus content in the air offers an alternative to traditional laboratory testing but does not replace it. Similarly, to create biosensors for COVID-19 testing, Rogue Valley Microdevices-a producer of microelectromechanical systems and sensors-is collaborating with early-stage companies like Cardea Bio & Hememics. Therefore, it is projected that these factors will spur market expansion throughout the forecast period.

The Embedded Device segment is expected to be the largest during the forecast period

The Embedded Device segment is estimated to hold the largest share, due to the significant surge in demand for embedded biosensors across multiple industries, such as healthcare, environmental monitoring, food and beverage, and consumer electronics. Embedded devices, a crucial subset of biosensors, involve the integration of biosensor technology into various systems, products, or platforms, enhancing their functionality and enabling real-time monitoring and analysis. Furthermore, these biosensors find applications in continuous glucose monitoring for diabetes management, wearable health trackers, environmental pollution monitoring, and smart packaging in the food industry, among others.

The Healthcare segment is expected to have the highest CAGR during the forecast period

The Healthcare segment is anticipated to have lucrative growth during the forecast period. The healthcare segment of the biosensors market is witnessing a transformative impact on patient care, disease management, and diagnostics. Biosensors have found extensive applications in glucose monitoring for diabetes, cardiac biomarker detection, pregnancy testing, infectious disease diagnosis, and drug-level monitoring. One of the significant advancements is the development of wearable biosensors, which facilitate continuous and non-invasive monitoring of vital signs, glucose levels, and other health parameters. In addition to this, these wearables provide valuable data to both patients and healthcare professionals, enabling proactive management of chronic conditions and timely interventions. With the potential to revolutionise healthcare delivery and improve patient outcomes, biosensors in the healthcare sector represent a vital and expanding market segment.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period, due to the region's vast population base and rising rates of various lifestyle disorders. Increasing demand for home healthcare, point-of-care services and other adult-focused healthcare enterprises in this region, as well as government initiatives to reduce hospital stays by developing outpatient care models. Regional statistics are also being fuelled by the launch of numerous health initiatives by national governments, the WHO, and organisations like Clinton Health Access Initiative, Inc. (CHAI). Additionally, the presence and availability of global brands and the challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the region data.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. Increased use of biosensors in this area for tracking food quality indicators is anticipated to support market growth. A rise in the market penetration of electronic medical records (EMR) and the development of miniaturised diagnostic equipment are predicted to drive market expansion over the forecasted period. In addition, the existence of the Clean Air Act, Clean Water Act, and National Environmental Policy Act in the U.S. is expected to open up opportunities for market expansion in North America. Moreover, the increase in demand for POC technologies in North America and the focus on rapid, simple, accurate, portable, and low-cost analytical instruments propel the market growth for the biosensors market in the region.

Key players in the market

Some of the key players in the Biosensor Market include: Bio-rad Laboratories, Nova biomedical, Acon laboratories, Eastprint incorporated, SD biosensor, Medtronic, Universal Biosensors, Conductive technologies, F. Hoffmann-La Roche Ltd, Innovative Sensor Technology AG, Pinnacle Technology, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Biosensors International Group, Ltd, Dexcom, Inc., QTL Biosystems, Danaher Corporation, DuPont Biosensor Materials and Johnson & Johnson.

Key Developments:

In April 2023, Medtronic plc announced that the US FDA had approved its 'MiniMed 780G' system with the Guardian 4 sensor requiring no fingersticks while in SmartGuard technology. The system provides insulin to account for situations where users occasionally forget to bolus or underestimate the number of carbs in their meal. It has been approved for users of and above seven years of age with type 1 diabetes.

In March 2022, Nova Biomedical launched the Nova Max Pro Creatinine/eGFR Meter System, a tool for improving kidney care through kidney function screening and early kidney disease detection in POC settings outside the hospital, in all CE countries. The Nova Max Pro meter and creatinine biosensor measure blood creatinine and calculate estimated glomerular filtration rate (eGFR) from a 1.2 microliter capillary fingerstick blood sample in 30 seconds.

In January 2022, Roche and Sysmex signed a Global Business Partnership Agreement (GBP) to supply hematological diagnostic services. Using IT technology, the new cooperation aims to enhance clinical decision-making and consumer experience. This long-standing, fruitful collaboration is still going strong, offering hematological diagnostic improvements to labs all over the world.

Types Covered:

  • Embedded Device
  • Sensor Patch
  • Other Types

Products Covered:

  • Non-wearable Biosensors
  • Wearable Biosensors

Technologies Covered:

  • Electrochemical Biosensors
  • Piezoelectric Biosensors
  • Nanomechanical Biosensors
  • Optical Biosensors
  • Thermal Biosensors
  • Other Technologies

Applications Covered:

  • Medical Testing
  • Drug discovery
  • Food Toxicity
  • Agricultural Testing
  • Industrial Process
  • Wastewater Treatment
  • Healthcare
  • Forensic and Biodefense
  • Food & Beverages
  • Point of care testing
  • Research laboratories
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biosensor Market, By Type

  • 5.1 Introduction
  • 5.2 Embedded Device
  • 5.3 Sensor Patch
  • 5.4 Other Types

6 Global Biosensor Market, By Product

  • 6.1 Introduction
  • 6.2 Non-wearable Biosensors
  • 6.3 Wearable Biosensors

7 Global Biosensor Market, By Technology

  • 7.1 Introduction
  • 7.2 Electrochemical Biosensors
  • 7.3 Piezoelectric Biosensors
  • 7.4 Nanomechanical Biosensors
  • 7.5 Optical Biosensors
  • 7.6 Thermal Biosensors
  • 7.7 Other Technologies

8 Global Biosensor Market, By Application

  • 8.1 Introduction
  • 8.2 Medical Testing
    • 8.2.1 Blood glucose testing
    • 8.2.2 Blood gas analysis
    • 8.2.3 Cholesterol testing
    • 8.2.4 Pregnancy testing
    • 8.2.5 Infectious disease testing
  • 8.3 Drug discovery
  • 8.4 Food Toxicity
  • 8.5 Agricultural Testing
  • 8.6 Industrial Process
  • 8.7 Wastewater Treatment
  • 8.8 Healthcare
  • 8.9 Forensic and Biodefense
  • 8.10 Food & Beverages
  • 8.11 Point of care testing
  • 8.12 Research laboratories
  • 8.13 Other Applications

9 Global Biosensor Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Bio-rad Laboratories
  • 11.2 Nova biomedical
  • 11.3 Acon laboratories
  • 11.4 Eastprint incorporated
  • 11.5 SD biosensor
  • 11.6 Medtronic
  • 11.7 Universal Biosensors
  • 11.8 Conductive technologies
  • 11.9 F. Hoffmann-La Roche Ltd
  • 11.10 Innovative Sensor Technology AG
  • 11.11 Pinnacle Technology
  • 11.12 Abbott Laboratories
  • 11.13 Thermo Fisher Scientific Inc.
  • 11.14 Siemens Healthineers AG
  • 11.15 Biosensors International Group, Ltd
  • 11.16 Dexcom, Inc.
  • 11.17 QTL Biosystems
  • 11.18 Danaher Corporation
  • 11.19 DuPont Biosensor Materials
  • 11.20 Johnson & Johnson

List of Tables

  • Table 1 Global Biosensor Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Biosensor Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Biosensor Market Outlook, By Embedded Device (2021-2030) ($MN)
  • Table 4 Global Biosensor Market Outlook, By Sensor Patch (2021-2030) ($MN)
  • Table 5 Global Biosensor Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global Biosensor Market Outlook, By Product (2021-2030) ($MN)
  • Table 7 Global Biosensor Market Outlook, By Non-wearable Biosensors (2021-2030) ($MN)
  • Table 8 Global Biosensor Market Outlook, By Wearable Biosensors (2021-2030) ($MN)
  • Table 9 Global Biosensor Market Outlook, By Technology (2021-2030) ($MN)
  • Table 10 Global Biosensor Market Outlook, By Electrochemical Biosensors (2021-2030) ($MN)
  • Table 11 Global Biosensor Market Outlook, By Piezoelectric Biosensors (2021-2030) ($MN)
  • Table 12 Global Biosensor Market Outlook, By Nanomechanical Biosensors (2021-2030) ($MN)
  • Table 13 Global Biosensor Market Outlook, By Optical Biosensors (2021-2030) ($MN)
  • Table 14 Global Biosensor Market Outlook, By Thermal Biosensors (2021-2030) ($MN)
  • Table 15 Global Biosensor Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 16 Global Biosensor Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Biosensor Market Outlook, By Medical Testing (2021-2030) ($MN)
  • Table 18 Global Biosensor Market Outlook, By Blood glucose testing (2021-2030) ($MN)
  • Table 19 Global Biosensor Market Outlook, By Blood gas analysis (2021-2030) ($MN)
  • Table 20 Global Biosensor Market Outlook, By Cholesterol testing (2021-2030) ($MN)
  • Table 21 Global Biosensor Market Outlook, By Pregnancy testing (2021-2030) ($MN)
  • Table 22 Global Biosensor Market Outlook, By Infectious disease testing (2021-2030) ($MN)
  • Table 23 Global Biosensor Market Outlook, By Drug discovery (2021-2030) ($MN)
  • Table 24 Global Biosensor Market Outlook, By Food Toxicity (2021-2030) ($MN)
  • Table 25 Global Biosensor Market Outlook, By Agricultural Testing (2021-2030) ($MN)
  • Table 26 Global Biosensor Market Outlook, By Industrial Process (2021-2030) ($MN)
  • Table 27 Global Biosensor Market Outlook, By Wastewater Treatment (2021-2030) ($MN)
  • Table 28 Global Biosensor Market Outlook, By Healthcare (2021-2030) ($MN)
  • Table 29 Global Biosensor Market Outlook, By Forensic and Biodefense (2021-2030) ($MN)
  • Table 30 Global Biosensor Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 31 Global Biosensor Market Outlook, By Point of care testing (2021-2030) ($MN)
  • Table 32 Global Biosensor Market Outlook, By Research laboratories (2021-2030) ($MN)
  • Table 33 Global Biosensor Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.